Tag: D Nageshwar Reddy

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to D Nageshwar Reddy

Is Covid-19 treatment based on trial and error?

Added to Collection on: 2021-05-31 05:15:00

Tags for this article:

Organic compounds
Drugs
Chemical compounds
COVID-19
Orphan drugs
Antiviral drugs
Organofluorides
Remdesivir
Treatment and management of COVID-19
Tocilizumab
Baricitinib
Dexamethasone
D Nageshwar Reddy
India
Viswesvaran Balasubramanian

Click the tags to see associated articles and topics

View Article Details
Covid patients relieved of symptoms in 24 hrs after taking antibody cocktail

Added to Collection on: 2021-06-15 15:45:11

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibodies
Biotechnology
Antiviral drugs
Immune system
Casirivimab/imdevimab
Antibody
Tolerx
D Nageshwar Reddy
Mohammed Shafeeq

Click the tags to see associated articles and topics

View Article Details
COVID-19 Patients Relieved of Coronavirus Symptoms in 24 Hours After Taking Antibody Cocktail ...

Added to Collection on: 2021-06-15 16:18:45

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibodies
Antiviral drugs
Biotechnology
COVID-19 drug development
Casirivimab/imdevimab
Antibody
TIMI
ZMapp
D Nageshwar Reddy
India

Click the tags to see associated articles and topics

View Article Details
24 hrs after taking antibody cocktail, COVID patients relieved of symptoms

Added to Collection on: 2021-06-16 03:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibodies
Biotechnology
Immune system
Antiviral drugs
Casirivimab/imdevimab
Antibody
TIMI
Tolerx
D Nageshwar Reddy

Click the tags to see associated articles and topics

View Article Details
Antibody cocktail lessens COVID symptoms in 24 hours after administration

Added to Collection on: 2021-06-16 05:03:45

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibodies
Biotechnology
Immune system
Antiviral drugs
Casirivimab/imdevimab
Antibody
Tolerx
ZMapp
D Nageshwar Reddy

Click the tags to see associated articles and topics

View Article Details
'Monoclonal Therapy Can 100% Tackle Severity of Delta Variant' - News18

Added to Collection on: 2021-11-02 22:10:24

Tags for this article:

Health sciences
Medical specialties
Medicine
Monoclonal antibodies
Antiviral drugs
COVID-19 drug development
Immune system
Casirivimab/imdevimab
Roche
COVID-19
Therapy
SARS-CoV-2 Delta variant
D Nageshwar Reddy
AIG
Nageshwar Reddy

Click the tags to see associated articles and topics

View Article Details